Stocks · News reference
HC Wainwright & Co. Reiterates Neutral on CareDx, Maintains $46 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral and maintains $46 price target.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BTIG Maintains Buy on CareDx, Raises Price Target to $60
BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $45 to $60.
CNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Other Big Stocks Moving Higher On Monday
Dow Jones index gained 600 points, CNH Industrial rose 16% after reporting better-than-expected Q2 results, other stocks also recording gains.
Why CareDx Stock Jumped Today
CareDx stock surged 14.72% after the precision medicine diagnostics company raised its full-year revenue and earnings forecasts. The company reported adjusted net income more than tripled to $20 million ($0.37 per share), significantly exceeding Wall Street estimates of $0.23 per share. Growth was driven by increased demand for non-invasive transplant monitoring tests, favorable reimbursement dynamics, and CMS coverage affirmation for kidney, heart, and lung transplant surveillance testing.